Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
In 1989, Novo Industri A/S (Novo Terapeutisk Laboratorium) and Nordisk Gentofte A/S (Nordisk Insulinlaboratorium) merged to become Novo Nordisk A/S, the world's largest producer of insulin with headquarters in Bagsværd, Copenhagen.
Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.
Novo Nordisk A/S is an international pharmaceutical research, development, and manufacturing corporation established in 1989 through the merger of competing Danish companies Nordisk Insulaboratorium and Novo Terapeutisk Laboratorium.
Novo Nordisk A/S | History, Structure, Products & Facts - Britannica Money
At Novo Nordisk, you will have the opportunity to build a life-changing career in a global business environment. Join us and make a difference.
Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
NNF India A/S Branch Office represents the Novo Nordisk Foundation in India, an independent Danish foundation with a mission to improve people’s health and the sustainability of society and...
AOL: Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?
The pharmaceutical industry has rarely seen a stock rise as spectacularly as Novo Nordisk (NYSE: NVO) did during the GLP-1 boom, only for it to plummet and surrender more than two-thirds of its value ...